anidulafungin has been researched along with Endotoxin Shock in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baietto, L; Corcione, S; D'Avolio, A; De Rosa, FG; Di Perri, G; Pasero, D; Ranieri, VM | 1 |
Henrich, M; Koch, C; Lichtenstern, C; Uhle, F; Weigand, MA; Wolff, M | 1 |
Álvarez-Escudero, J; Dominguez, D; Giménez, MJ; González-Serrano, M; Granizo, JJ; Maseda, E; Mouriz, L; Ojeda, N; Rodríguez-Manzaneque, M; Sánchez-Zamora, P | 1 |
3 other study(ies) available for anidulafungin and Endotoxin Shock
Article | Year |
---|---|
Pharmacokinetics of anidulafungin in two critically ill patients with septic shock undergoing CVVH.
Topics: Aged; Anidulafungin; Antifungal Agents; Area Under Curve; Candidemia; Critical Illness; Echinocandins; Female; Hemofiltration; Humans; Male; Middle Aged; Shock, Septic | 2013 |
Cardiac Effects of Echinocandins in Endotoxemic Rats.
Topics: Anidulafungin; Animals; Antifungal Agents; Cardiac Output; Cardiac Volume; Caspofungin; Echinocandins; Endotoxemia; Female; Heart; Hemorheology; Humans; Lipopeptides; Lipopolysaccharides; Male; Micafungin; Myocytes, Cardiac; Primary Cell Culture; Rats; Rats, Inbred Lew; Shock, Septic | 2016 |
Intraabdominal candidiasis in surgical ICU patients treated with anidulafungin: A multicenter retrospective study.
Topics: Abdomen; Abdominal Abscess; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Critical Care; Echinocandins; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Peritonitis; Retrospective Studies; Shock, Septic; Spain; Treatment Outcome | 2016 |